FDA Finally Set To Approve Multiple Sclerosis Drug This March, Is There A Catch?
Hope for Multiple Sclerosis patients has once again been revived after it was recently announced that the cure to overcome the illness is soon to be launched. Putting emphasis to those inflicted with progressive types of MS who have not found a drug that has the ability of working to reduce flares, improve symptoms, or slow disease progression. As of the press time, it was found that nearly 2.3 million people worldwide are living with the disease.
FDA On Approving Multiple Sclerosis Drug This March
According to reports revealed by Health Line, after series of delays, the Food and Drug Administration is finally set to approve a certain drug that is believed to have the ability in curing the disease late March this year. Officials from Roche Pharmaceuticals, the developer of the said cure has also claimed that for the first time ever, people with primary progressive MS (PPMS) may benefit from what they consider to be a medical breakthrough. During the large scale phase III trial, the drug named as Ocrevus has reportedly shown to significantly slow the progression of physical disability in people with PPMS. However, despite the success of these trials, the production of Ocrevus or also known as ocrelizumab has been delayed.
Why Has It Been Delayed?
Meanwhile, as per Multiple Sclerosis News Today, due to manufacturing issues, the long-awaited approval of FDA has been pushed to late March 2017. Additionally, Genentech, a member of the Roche Group, has explained that the U.S. Food and Drug Administration (FDA) has decided to extend the Prescription Drug User Fee Act (PDUFA) due to the submission of additional data by Genentech regarding the commercial manufacturing process of Ocrevus, which required additional time for FDA review. Furthermore, Genentech clarifies that the reason was actually contrary to the speculations that the reason was about the efficacy or safety of Ocrevus.
Elon Musk Is Working On A Consensual Telepathy; Latest Details Inside
Elon Musk has confirmed that Neuralink is real and that he is serious about the technology. The firm will soon develop a “neural lace” technology that would involve implanting tiny brain electrodes.
President Trump Nominates Conservative Physician, Scott Gottlieb, To Head the FDA
President Donald Trump has nominated Dr. Scott Gottlieb as potential had of the US Food and Drug Administration (FDA) agency. Gottlieb is regarded as a conservative physician and businessman with extensive experience of how the pharmaceutical industry is run. In fact, many voices in the health industry call for the US Senate to approve his nomination for the job.
The Controversial ‘Liberation Therapy’: Is It Good For Multiple Sclerosis?
With the number of advancements that has been intended for Multiple Sclerosis, why is the so-called ‘Liberation Therapy’ found to ineffective? What makes the said therapy to be considered as a failure when it comes to treating the auto-immune disease? Could it mean that it’s now a hopeless case for one of the world’s most dreaded diseases? Here’s what experts have to say
Multiple Sclerosis May Now Be Predicted Through Fatigue And Leg Dysfunction, Experts Say
Considering that the emergence of Multiple Sclerosis is still being considered as mysterious, are there ways to predict if a person is at risk of developing the said auto-immune disease? What’s the truth behind claims that Fatigue and Leg Dysfunction may be used as onset identifiers of the disease? Find out what health experts have to say
FDA Approves Xermelo, A Drug For Carcinoid Syndrome Diarrhea
What is Carcinoid Syndrome Diarrhea? With the number of biotechnology companies venturing on the development of drugs to cure certain diseases, how is Lexicon’s drug for carcinoid syndrome different from other drugs that also aims to halt the said disease? Since FDA has already approved it, does it hold the promise of cure? Find out what experts have to say
Recovery From Multiple Sclerosis Found In The So-Called 'tDCs' Technology, Details Inside
What is 'tDCs'? Considering that Multiple Sclerosis has been one of the world's fast emerging diseases, can the cure be found in this new technology called 'tDCs'? How can a patient recover from the aid auto-immune disease with the help of this technology? Here's what health professionals have to say
MORE IN ITECHPOST
'Tokyo Ghoul' Season 3 Delayed By Its Live-Action Movie? Ken Kenaki Returns With Another Identity?
"Tokyo Ghoul" season 3's release is delayed and there are countless speculations as to why it is being pushed back. Reports claim that the show is to give way to "One Punch Man" and "My Hero Acdemia" but new rumors say that it's lack of materials and storyline as well as its live-action movie are causing the delay.
‘Resident Evil 7: Not A Hero DLC’ First Gameplay Trailer Leaks Online
First gameplay trailer pertaining to RE7: Not A Hero DLC has just leaked on YouTube.